4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0000950170-25-086307
Options or other derivatives
- Director acquired 152,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| BAKER BROS. ADVISORS LP Director | 2025-06-12 | Grant or award · Non- Qualified Stock Option (right to buy) | +76,000 | 76,000 | I | ||
| BAKER BROS. ADVISORS LP Director | 2025-06-12 | Grant or award · Non- Qualified Stock Option (right to buy) | +76,000 | 76,000 | I | ||
Loading xslF345X05/ownership.xml…